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Reactive oxygen species (ROS) are critical deter-
minants of the fate of hematopoietic stem cells
(HSCs) and hematopoiesis. Thioredoxin-interacting
protein (TXNIP), which is induced by oxidative stress,
is a known regulator of intracellular ROS. Txnip/
old mice exhibited elevated ROS levels in hemato-
poietic cells and showed a reduction in hematopoiet-
ic cell population. Loss of TXNIP led to a dramatic
reduction of mouse survival under oxidative stress.
TXNIP directly regulated p53 protein by interfering
with p53- mouse double minute 2 (MDM2) interac-
tions and increasing p53 transcriptional activity.
Txnip/ mice showed downregulation of the antiox-
idant genes induced by p53. Introduction of TXNIP or
p53 into Txnip/ bone marrow cells rescued the
HSC frequency and greatly increased survival in
mice following oxidative stress. Overall, these data
indicate that TXNIP is a regulator of p53 and plays
a pivotal role in the maintenance of the hematopoiet-
ic cells by regulating intracellular ROS during oxida-
tive stress.
INTRODUCTION
Oxidative stress occurs mainly due to excessive accumulation of
cellular reactive oxygen species (ROS) or deficiency of antioxi-
dant defense system. Oxidative stress often leads to pathologic
diseases such as diabetes, neurodegenerative diseases, and
cancer (Hole et al., 2011; Sinha et al., 2013). There is growing ev-
idence that balanced regulation of ROS is critical for hematopoi-
esis. Hematopoietic cells are vulnerable to oxidative stress, andmalignancy of hematopoietic tissues is observed in the presence
of chronic oxidative stress (Ghaffari, 2008). Homeostatic regula-
tion of redox status in hematopoietic tissues is important for
normal hematopoiesis.
Thioredoxin-interacting protein (TXNIP) is a 397 amino acid,
50 kDa protein that belongs to the arrestin family, and Txnip/
mice show a high incidence of hepatocellular carcinoma (HCC)
(Jeong et al., 2009; Kwon et al., 2011; Lee et al., 2005; Song
et al., 2003). TXNIP expression is reduced in many types of
tumors, and TXNIP overexpression inhibits tumor growth by
blocking cell-cycle progression (Han et al., 2003). The numbers
of natural killer (NK) cells in the bone marrow (BM) of Txnip/
mice are reduced, and the long-term reconstituting HSC popula-
tion shows an exhausted phenotype and is reduced in frequency
(Jeong et al., 2009; Lee et al., 2005).
The tumor suppressor p53 plays a key role in restricting the
expansion of abnormal cells through either growth arrest or
apoptosis in response to genotoxic stresses (Olovnikov et al.,
2009; Sablina et al., 2005). The p53 pathway is regulated by
mouse double minute 2 (MDM2), an E3 ubiquitin ligase that tar-
gets the p53 protein for proteasomal degradation (Sasaki et al.,
2011). p53 engages powerful prosurvival pathways by inducing
the expression of antiapoptotic or antioxidant genes (Bensaad
and Vousden, 2007; Ja¨nicke et al., 2008). In addition, p53 is a
critical regulator of HSC quiescence through its target genes
(Liu et al., 2009). Previous reports imply that the protective or
antiaging effects of TXNIP are important in maintaining hemato-
poietic cell pool (Jeong et al., 2009; Kim et al., 2007).
In this study, we demonstrate that Txnip/ hematopoietic
cells had defects in the regulation of ROS levels and were
more sensitive than wild-type cells to oxidative stress. We also
demonstrated that TXNIP exerted its antioxidant effects in he-
matopoietic cells by stabilizing p53 under oxidative stress. Our
findings suggest that TXNIP plays a critical role in the antioxidant
defense mechanisms of hematopoietic cells by activating the
p53 pathway during oxidative stress.Cell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc. 75
Figure 1. Defects of Hematopoietic Cell Pool in KO Mice
(A) Reduced frequencies of HSCs and progenitors in KOmice (n = 4). The frequencies of HSCs and progenitors in young (12weeks) and oldmice (23months) were
analyzed by flow cytometry.
(B) Experimental design for competitive repopulation assays and serial BMT assays.
(C) Decreased donor-derived cell population in old KOmice (n = 5).We transplanted LKS cells (53 103) from young (12weeks) and old (23months)WT or KOmice
in combination with competitor cells (1.0 3 106) from congenic (CD45.1+) mice into lethally irradiated wild-type (WT) congenic (CD45.1+) recipients.
(D) Distribution of donor-derived HSCs (CD45.2+) among recipient BM cells 16 weeks after transplantation (n = 5).
(E and F) Decreased donor-derived cell population of KOWBM cells after serial transplantation (n = 5). At 16 weeks after the first BMT, we serially injected young
donor-derived WBM cells from recipients into a second set of recipient mice (CD45.1). After another 16 weeks, the donor-derived immune cells and frequency of
HSCs were examined in the PB (E) and BM (F), respectively. All data are mean ± SD. *p < 0.05, **p < 0.01. See also Figure S1.
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Defects of Hematopoietic Cell Maintenance in Txnip–/–
Mice Are Caused by Elevated ROS
To investigate the effects of TXNIP deficiency on hema-
topoiesis, we analyzed the frequency of hematopoietic stem
cells (HSCs) and hematopoietic progenitors from young
(12 weeks) and old (22–23 months) Txnip+/+ (wild-type [WT])
and Txnip/ (KO)mice. Consistent with previous reports (Geiger
and Van Zant, 2002; Sudo et al., 2000), old WT mice showed
much higher frequencies of HSCs and hematopoietic progeni-
tors, but old KO mice showed relatively decreased frequencies
(Figure 1A). Next, we performed a competitive repopulation
assay and a serial bone marrow transplantation (BMT) experi-
ment (Figure 1B). We transplanted lineagec-Kit+Sca-1+ (LKS)
cells or WBM (whole bone marrow) cells from young (12 weeks)
and old (22–23 months) mice (CD45.2+) with competitor WBM
cells (CD45.1+) into congenic recipients (CD45.1+). Donor-
derived cell populations of oldWT LKSorWBMcell-transplanted
recipients showed little change, but those of old KO LKS orWBM76 Cell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc.cell-transplanted recipients weremarkedly decreased (Figure 1C
and Figure S1A available online). Also, WBM cells of recipients
from young and old KO mice showed a greater reduction in
donor-derived cell populations of HSCs and progenitors than
those from WT mice (Figures 1D, S1B, and S1C), mostly due to
the reduced frequency of HSCs and progenitors in donor WBM
or LKS as shown in Figure 1A. Next, we performed a serial
BMT experiment. Donor-derived CD45.2+ cells were dramati-
cally decreased in the KO-derived recipient cells (Figures 1E
and 1F).
The exhaustion of primitive HSCs is believed to result from
increased ROS accumulation following serial transplants, which
are a critical determinant of HSC pool maintenance (Abbas et al.,
2010; Ito et al., 2006). We found dramatically increased ROS
levels in old KO BM cells compared with those from WT litter-
mates (Figure 2A). To assess the effects of the intrinsic increase
in ROS on the maintenance of KO BM cells, we transplanted
WBM cells (CD45.2+) into lethally irradiated WT congenic
(CD45.1+) recipients. After 9 months, we confirmed higher levels
of ROS in the KO-derived BM cells (Figure 2B). Our observations
Figure 2. Regulation of ROS in Hematopoi-
etic Cells by TXNIP under Oxidative Stress
(A) Elevation of ROS in KOmice (n = 4). ROS levels
were measured by DCF staining using flow cy-
tometry from young (12 weeks) and old
(23 months) mice.
(B) Elevation of ROS in KO-derived cells
after transplantation at 9 months (n = 5). WBM
cells (CD45.2+, 2.5 3 106) from WT or KO
mice were noncompetitively transplanted into
lethally irradiated WT congenic (CD45.1+) re-
cipients.
(C and D) Time kinetics of ROS (C) and apoptosis
(D) of hematopoietic cells after PA (40 mg/kg)
challenge. All data are mean ± SD. *p < 0.05. See
also Figure S2.
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TXNIP Is a Functional Switch in Oxidative Stresssuggested that TXNIP plays a critical role in hematopoietic cell
antioxidant defense through mechanisms other than its known
prooxidant function as an inhibitor of thioredoxin (Trx) (Lee
et al., 2005; Patwari et al., 2006; Schulze et al., 2002).
To examine the specificity of antioxidant defense by TXNIP
in hematopoietic cells, we analyzed the levels of ROS in WT
and KO mouse embryonic fibroblast (MEF) and lung fibroblast
cells under oxidative stress. Interestingly, WT MEF and lung
fibroblast cells showed the prooxidant function of TXNIP
following oxidative stress (Figures S2A–S2D), indicating that
TXNIP regulates ROS levels in a cell-type-specific manner.
Next, to validate the antioxidant function of TXNIP in hematopoi-
etic cells under oxidative stress, we intraperitoneally (i.p.) in-
jected paraquat (PA), a strong oxidative stress inducer, into
young mice. Consistent with our observations of old KO mice,
young KO mice showed higher ROS levels and increased cell
death in BM cells following PA challenge (Figures 2C and 2D).
KO HSCs showed lower ROS levels than nonprimitive cells but
also hypersensitivity under oxidative stress. KO HSCs entered
into the cell cycle at an early time (0–12 hr) but showed
decreased proliferating rates and frequencies at a late time
(48–96 hr) following PA challenge (data not shown) (Macip
et al., 2003). Taken together, the above data indicate that TXNIP
shows cell-type-specific antioxidant function and plays an
important role in themaintenance of both HSCs and nonprimitive
hematopoietic cells by regulating ROS and cell death following
oxidative stress.
TXNIP Regulates Hematopoietic Cell Maintenance
under Oxidative Stress
Next, we tested the effects of oxidative stress on TXNIP-
mediated hematopoietic cell maintenance (Figure 3A). PA-Cell Metabolism 18,pretreated KO BM cells showed a re-
duction in donor-derived cell populations
in recipients (Figures 3B, 3C, S3A,
and S3B). PA-challenged KO BM cells
also showed decreased colony-forming
unit-spleen (CFU-S) numbers (Figure 3D)
and a lower survival rate in a radio-
protection assay compared to WT (Fig-
ure 3E). Overall, these findings suggest
that TXNIP maintains the hematopoi-etic cell pool by regulating ROS levels in vivo following
oxidative stress.
TXNIP Acts as an Antioxidant Protein In Vivo
Based on its roles in hematopoietic cell maintenance, we tested
the effects of TXNIP deficiency on the hematopoietic system in
terms of protection against oxidative stress in vivo. We chal-
lenged mice with 40 mg/kg PA. The KO mice all died within
160 hr, but none of the WT mice died during this time period —
they survived more than 2 months. Treatment with N-acetylcys-
teine (NAC), an antioxidant agent, rescued up to 70%of KOmice
(Figure 4A). PA-induced lethality in KOmice was dose and geno-
type dependent (Figures S4A and S4B). To exclude the possibil-
ity of toxic effects on other tissues and to determine the intrinsic
response of hematopoietic cells to oxidative stress, we per-
formed BMT experiments. After 8 weeks, we challenged mice
with 40 mg/kg PA. All of the mice that received KO WBM cells
died within 150 hr, but 70% of the mice that received WT
WBM cells survived (Figure 4B). Next, we examined the spleen
and thymus following PA challenge. Spleen size and cellularity
were markedly decreased in KO mice (Figures 4C, S4C, and
S4D). Mice receiving KOWBMalso showed a decrease in spleen
size following PA challenge (Figure S4E). Similarly, we observed
cellular apoptosis in the spleens of PA-treated KOmicewith both
TUNEL and annexin V staining (Figure 4D). In addition, PA-
treated KO mice showed significant damage to the thymus (Fig-
ure 4E) and decreased body weight (Figure S4F).
To measure the effects of oxidative stress on host immune de-
fenses, we evaluated lung metastasis. Lung metastasis was
markedly increased in PA-challenged KO mice (Figure 4F). PA-
challenged KO mice also showed markedly reduced numbers
of immune cells associated with tumor cytotoxicity in the spleen75–85, July 2, 2013 ª2013 Elsevier Inc. 77
Figure 3. Loss of Hematopoietic Cell Popu-
lation in KOMice FollowingOxidative Stress
(A) Experimental design for competitive re-
population assay, CFU-S assay, and radiopro-
tection assay.
(B) Defects of donor-derived cell population in PA-
pretreated KO BM cells (n = 5).
(C) Loss of donor-derived hematopoietic cell
population in recipients of BM from PA-pretreated
KO mice (n = 5).
(D) Decreased CFU-S numbers in recipients
derived from PA-pretreated KO mice (n = 5). After
7 days, the spleens were fixed and the colonies
were counted.
(E) Decreased radioprotective function of PA-
pretreated KO BM cells (n = 10 per group). The
recipient survival was scored and presented as a
Kaplan-Meier survival curve. All data are the
mean ± SD. *p < 0.05. See also Figure S3.
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TXNIP Is a Functional Switch in Oxidative Stress(Figures S4G–S4I). We further confirmed the immune cell anti-
metastatic response through BMT. As expected, lung metas-
tasis markedly increased in the mice receiving KO WBM cells,
and thesemice showed elevated ROS levels of splenocytes (Fig-
ures 4G and S4J). Collectively, we found preferential toxic ef-
fects of PA on KO immune cells; therefore, KO mice could not
maintain functional immune system after PA challenge. These
data indicate that TXNIP acts as an antioxidant protein in he-
matopoietic cells by regulating ROS.
TXNIP Is Correlated with p53-Mediated ROS Regulation
in Hematopoietic Cells
We previously reported that TXNIP expression was highest in
long-term (LT)-HSCs and gradually decreased during the pro-
gression to short-term (ST)-HSCs and multipotent progenitors
(MPPs) (Jeong et al., 2009). To understand the correlation be-
tween TXNIP and ROS in BM cells, we examined intracellular
ROS and TXNIP levels in BM cells. Interestingly, an inverse cor-
relation was observed between ROS and TXNIP levels in BM
cells (Figures 5A and 5B). Recent reports have suggested that
the tumor suppressor protein p53 has antioxidant functions
and is highly expressed in HSCs. Accordingly, p53/ mice
showed increased ROS levels and dysregulated HSC quies-
cence (Liu et al., 2008, 2009; Sablina et al., 2005). To evaluate
the potential correlation between TXNIP and p53 in BM cells,
we measured p53 levels by staining for intracellular p53. The
expression of p53 was markedly decreased in KO BM cells (Fig-
ure 5C), which was accompanied by higher ROS levels in KO BM
cells (Figure 5D). These data strongly suggested a correlation
between TXNIP and p53 expression and ROS regulation. Based
on the observation of smaller differences in p53 levels and larger78 Cell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc.differences in ROS levels in KO BM cells
compared with those in WT BM cells, it
seems that ROS is not entirely regulated
by p53 in KO BM cells or is more sensitive
to a change of p53 level without TXNIP.
To determine the function of p53 in he-
matopoietic cells on ROS regulation, we
analyzed the levels of ROS in p53/ he-
matopoietic cells. p53/ hematopoietic cells showed higher
levels of ROS than WT cells (Figure 5E). To evaluate the double
knockdown effect of TXNIP and p53 on ROS regulation in he-
matopoietic cells, we introduced p53 small hairpin RNA (shRNA)
into sorted KO LKS cells in vitro or challenged pifithrin-a (PFT-a),
a specific p53 inhibitor, in vivo (Komarov et al., 1999; Liu et al.,
2004; Sohn et al., 2009). The effects of shRNAs or PFT-a on
p53 and its target gene expression were confirmed (Figures
S5A and S5B). The levels of ROS were further increased in
Txnip/ hematopoietic cells by treating p53 shRNA or PFT-a
(Figures 5F and 5G). To examine the antioxidant functions of
p53 under oxidative stress, we challenged PA into p53/ mice
or PFT-a-pretreated mice. p53/ hematopoietic cells showed
the increased ROS levels following PA challenge (Figures 5H–
5J). When PA (50 mg/kg) was injected into WT and p53/
mice, p53/ mice were more sensitive to PA challenge (Fig-
ure 5K). Furthermore, when PA (40 mg/kg) was injected into
WT, Txnip/, and Txnip//PFT-a mice, Txnip//PFT-a mice
were most sensitive to oxidative stress (Figure 5L). These results
strongly suggest that TXNIP works in conjunction with p53 to
regulate ROS levels in hematopoietic cells.
Regulation of p53 Activity by TXNIP via Direct
Interaction
p53 and TXNIP were induced and colocalized in the nucleus
following H2O2 treatment in MCF7 (human breast adenocarci-
noma) (Figure S6A). These data suggest the possibility of a direct
subcellular interaction between TXNIP and p53, so we next
examined the interaction between TXNIP and p53. These mole-
cules appeared to directly interact with each other (Figure S6B).
Serial mutations of TXNIP followed by glutathione S-transferase
Figure 4. TXNIP Regulates the Homeostasis of the Immune System under Oxidative Stress
(A) Mice survival assay. WT or KOmice were challenged with PA (40mg/kg). For NAC rescue, we injected 100mg/kg NAC daily starting at day1. Mice survival is
presented as a Kaplan-Meier survival curve (n = 10 per group).
(B) Mice survival assay after BMT (n = 10 per group). WBM cells (CD45.2+, 2.5 3 106) from WT and KO mice were injected into lethally irradiated WT congenic
(CD45.1+) recipients. After 8 weeks, assays were performed using the same methods as described in (A).
(C) Hematoxylin and eosin (H&E) stained images (4003) and spleen cellularity (n = 5). WT or KO mice were challenged with PA (40 mg/kg) for 96 hr.
(D) Apoptosis of splenocytes (n = 5). Spleens were stained with TUNEL or annexin V for the apoptosis assay. Representative images of TUNEL-stained spleen
(left, 4003) and annexin V splenocytes are shown.
(E) Thymus damage following oxidative stress (n = 4). WT or KO mice were challenged with PA (40 mg/kg) for 96 hr.
(F) Lung metastasis induced in KO mice by oxidative stress (n = 5).
(G) Induced lung metastasis in KO-derived recipients after BMT. These experiments were independently repeated twice. The results are shown as a repre-
sentative photograph of metastatic nodules on the lungs (n = 4). All data are mean ± SD. *p < 0.05. See also Figure S4.
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TXNIP Is a Functional Switch in Oxidative Stress(GST) pull-downs revealed that two cysteine residues (247 and
267) of TXNIP were critical for their interaction (Figure 6A) (Shin
et al., 2008). To determine the p53 residues necessary for this
interaction, we generated two deletionmutants by deleting either
the N-terminal or C-terminal DNA-binding domain (DBD) of the
p53. TXNIP interacted with the C-terminal DBD region of p53,
which contains five cysteines (Figure 6B). Interactions between
TXNIP and p53 were increased, but TXNIP dissociated from
Trx following H2O2 treatment (Figure 6C). Furthermore, to deter-
mine the status of the Trx-Trx reductase system in Txnip/ he-
matopoietic cells, we examined the level of Trx and measured
the enzyme activity. The expression and reducing activity of
Trx was not changed in KO LKS or lineagec-Kit+ (LK) cells but
significantly increased in KO lung fibroblasts (Figures S6C–
S6F). These results suggest cell-type-specific regulation of Trx
by TXNIP.
Next, we investigated the interaction between TXNIP and p53
by redox stress. The dithiothreitol (DTT)-treated TXNIP showeddecreased coprecipitation with p53, which was not altered
following H2O2 treatment in vitro (Figure S6G) (Jung et al.,
2008). We also examined the oxidation of TXNIP under acute
oxidative stress. Redox blot showed the oxidized TXNIP
following H2O2 treatment (Figure S6H). To investigate the phys-
iological consequences of the interaction between TXNIP and
p53, we examined the cellular levels of p53 in TXNIP (WT) or
TXNIP (C247S/C267S [DM])-overexpressing cells. Cellular levels
of p53 were increased by TXNIP (WT) expression, but not by
TXNIP (DM) in Baf3 cells (murine bone marrow-derived pro-B
cells) (Figure 6D). To determine whether the increase of p53
was dependent on its protein level, we examined the level of
p53 transcripts in Txnip/ cells. RT-PCR revealed no significant
changes of p53 messenger RNA (mRNA) expression in the
absence of TXNIP (Figure S6I).
Next, we investigated the effects of TXNIP or TXNIP-small
interacting RNA (siRNA) on p53 stability. p53 levels were
retained in TXNIP overexpressing cells, but TXNIP-siRNACell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc. 79
Figure 5. Inverse Correlation between TXNIP and p53 Expression and ROS in BM Cells
(A) ROS levels in WT BM cells (n = 3). ROS levels were measured by the DCFDA assay using flow cytometry.
(B and C) Intracellular staining for TXNIP (B) and p53 (C) in WT or KO BM cells (n = 3). BM cells were stained with surface markers and anti-TXNIP or -p53
antibodies.
(D) ROS levels in WT and KO BM cells (n = 4).
(E) Elevation of ROS in Txnip/ and p53/ HSCs and LKS cells (n = 3).
(F) Increased ROS levels in LKS cells fromWT and KOmice by TXNIP shRNA or p53 shRNA introduction (n = 3). We introduced TXNIP shRNA and p53 shRNA into
LKS cells 3 times for 3 days in vitro. These experiments were independently repeated 2 times.
(G) Elevation of ROS inWT and KOHSCs following p53 inhibitor (PFT-a) treatment (n = 4). We injected PFT-a (5 mg/kg) intoWT or KOmice. After 48 hr, mice were
killed, and we analyzed their ROS levels of BM cells.
(H–J) Increased ROS in p53/ hematopoietic cells after PA challenge (n = 3). WT and p53/mice were treated with PA (40mg/kg) for 24 hr. (H) Increased ROS in
p53/ CD150+CD48LKS cells. (I) Increased ROS in p53/ LKS cells. (J) Increased ROS in p53/ splenocytes.
(K) Mice survival assay (n = 10 per group). WT or p53/ mice were challenged with PA (50 mg/kg). Mice survival was scored every 12 hr and presented as a
Kaplan-Meier survival curve.
(L) Mice survival assay (n = 10 per group). We injected PFT-a (5 mg/kg) into KO mice 24 hr before PA injection and then injected PA (40 mg/kg) into WT, KO, and
KO/PFT-a mice. All data are mean ± SD. *p < 0.05. See also Figure S5.
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TXNIP Is a Functional Switch in Oxidative Stressreduced p53 stability (Figure S6J). The stability of p53 is
tightly regulated by MDM2, an E3 ubiquitin ligase, via ubiquiti-
nation-dependent proteasomal degradation (Sasaki et al.,
2011). Therefore, we examined the effects of TXNIP on
p53-MDM2 interactions. TXNIP significantly decreased the
association between p53 and MDM2 (Figures 6E and S6K).
Consistently, p53 ubiquitination was markedly decreased in
TXNIP-overexpressing cells (Figure S6L). Furthermore, the
physical interaction between TXNIP and p53 also markedly
increased p53-mediated transcriptional activity in cells (Fig-
ure 6F). Collectively, these results indicate that TXNIP
increased p53 stability by interfering with the interactions be-
tween p53 and MDM2, thereby inducing the transcriptional ac-
tivity of p53.80 Cell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc.TXNIP Mediates the Antioxidant Effect of p53 In Vivo
The above results strongly suggested the possibility that TXNIP
regulated the antioxidant activity of p53 through the expression
of p53-dependent antioxidant genes. WT LKS cells showed
higher expression of p53 and its target genes, SESN1 and
SESN2 (Figure 7A), and similar expression of p53 target genes
was observed in WT LK cells by western blot (Figure 7B). Next,
we showed differential expression of p53 target antioxidant
genes inWT and KO LKS cells (Figure 7C). Interestingly, stronger
induction of p53 target prooxidant genes was observed in KO
LKS cells at 24 hr under oxidative stress (Figure 7D), whichmight
correlate with p53 activation by excessively elevated ROS levels
(Figures 2C and S7A), similar to that observed in old KO mice
(Figure 2A). The expression of TXNIP was increased, and
Figure 6. TXNIP Interacts with p53 and Regulates its Transcriptional Activity
(A) TXNIP interacts with p53 via its cysteine residues C247 andC267.We cotransfected p53- and TXNIP-encoding vectors into 293T cells. The protein complexes
were analyzed using GST pull-down assay as described previously (Jung et al., 2008; Shin et al., 2008).
(B) p53 interacts with TXNIP via its C-terminal DBD.
(C) Interaction of TXNIP with p53 or Trx following H2O2 treatment. Baf3 cells were treated with H2O2 (0.5 mM) for 6 hr. Cell lysates were immunoprecipitated with
TXNIP antibodies.
(D) Induction of p53 by TXNIP overexpression. Baf3 cells were transiently transfected with pMYs-IRES-GFP vector, pMYs-IRES-GFP-mTXNIP, or pMYs-IRES-
GFP-mTXNIP (DM). The cells were immunostained with anti-p53 and then analyzed by confocal microscopy.
(E) Regulation of the p53-MDM2 complex by TXNIP expression. pMYs-IRES-GFP vector, pMYs-IRES-GFP-mTXNIP, or pMYs-IRES-GFP-mTXNIP(DM) was
transfected into Baf3 cells, and interaction was determined by immunoprecipitation with anti-p53 antibody.
(F) Induction of the transcriptional activity of p53 by TXNIP. Baf3 cells were transfected with increasing amounts of TXNIP or TXNIP (DM), as indicated, along with
p53-luciferase reporter and pRL-CMV plasmid vectors. All of the experiments were independently repeated at least three times, and data are mean ± SD. *p <
0.05. See also Figure S6.
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TXNIP Is a Functional Switch in Oxidative Stressdifferential kinetics of p53 activation was observed under oxida-
tive stress in lineage cells (Figure 7E). Additionally, we found
higher levels of p53 and its target genes accompanied by
elevated apoptosis and cell-cycle arrest in old KO mice, sug-
gesting that p53 was activated by the elevated ROS levels in
old KO mice (Figures S7B–S7D).
Next, to provide direct evidence that the p53 antioxidant func-
tion was regulated by interactions with TXNIP in vivo, we intro-
duced TXNIP(WT), TXNIP(DM), or p53 into KO BM cells and
then transplanted them into lethally irradiated WT congenic
(CD45.1+) recipients. Expression of TXNIP(WT), TXNIP(DM), or
p53 in KOBMcells was confirmed by real-time PCR (Figure S7E).
After 8 weeks, mice were challenged with 40mg/kg PA and were
examined for changes in the frequency of HSCs and progenitorsand mice survival. Introduction of TXNIP(WT) or p53 rescued the
frequencies of KO donor (CD45.2) hematopoietic cells and
showed higher survival rates, but the TXNIP(DM) mutant did
not (Figures 7F and 7G). Thus, our results provided direct evi-
dence that the antioxidant effect of TXNIP was mediated by in-
teractions with the p53 pathway in vivo.
DISCUSSION
Oxidative stress basically defines a condition in which the pro-
oxidant-antioxidant balance in the cell is disturbed. In hemato-
poietic cells, the defects of antioxidant pathways can lead to
oxidative stress and deficiencies in several ROS scavengers, re-
sulting in anemia and malignancies of hematopoietic tissuesCell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc. 81
Figure 7. TXNIP Regulates the Antioxidant Effect of p53 in Hematopoietic Cells
(A) Intracellular staining of p53 target genes in LKS cells.
(B) Expression of p53 target genes in lineagec-Kit+ (LK) cells.
(C) Regulation of p53 target antioxidant genes in WT and KO LKS cells.
(D) Regulation of p53 target prooxidant genes inWT and KO LKS cells after PA challenge. WT and KOmice were challenged with PA (40mg/kg) for 24 hr, and p53
target genes were evaluated by quantitative real-time PCR.
(E) Time kinetics of p53 expression in WT and KO lineage BM cells following PA (40 mg/kg) treatment.
(F) Rescue of HSCs and progenitors from oxidative stress by introducing TXNIP and p53 genes into KO BM cells (n = 4 or 5 per group). After 8 weeks, the re-
cipients were challenged with PA (40 mg/kg) for 96 hr.
(G) Rescue of mice survival by introducing TXNIP and p53 into KOBM cells. Transplanted recipients were challenged with PA (40mg/kg), andmouse survival was
presented as a Kaplan-Meier survival curve (n = 8 per group).
(H) TXNIP acts as a functional switch to determine the cellular function of p53 in hematopoietic cells in response to oxidative stress. TXNIP can regulate the
context of hematopoietic cells by regulating the activity of p53 under oxidative stress.WT hematopoietic cells are ready to defend ROS stress by inducing the p53
target antioxidant genes, but KO hematopoietic cells are damaged by elevated ROS, resulting from the reduction of antioxidant genes expression. All data are
mean ± SD. *p < 0.05. See also Figure S7.
Cell Metabolism
TXNIP Is a Functional Switch in Oxidative Stress(Ghaffari, 2008; Sinha et al., 2013). Thus, the excessive oxidative
stress impairs hematopoietic cell functions and leads to
abnormal hematopoiesis.
We first showed that ROS levels were elevated in TXNIP KO
hematopoietic cells and determined that elevated ROS levels
induced hematopoietic cell apoptosis in Txnip/ mice and
impaired their subsequent hematopoiesis, consistent with previ-
ous reports (Blank et al., 2008; Naka et al., 2008). Accumulating
research indicates the importance of ROS in hematopoietic cells
and that levels can become elevated following the loss of func-82 Cell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc.tional genes (Ito et al., 2004; Miyamoto et al., 2007). In this study,
we observed an antioxidant effect of TXNIP in hematopoietic
cells undergoing oxidative stress. TXNIP is also a candidate tu-
mor suppressor, and its expression is dramatically reduced in
various tumor tissues (Kwon et al., 2010). Tumor cells have
high levels of ROS, and TXNIP protein levels are markedly
decreased in renal cell carcinoma (Dutta et al., 2005; Gupta
et al., 1999). Meanwhile, the prooxidant function of TXNIP was
observed in nonhematopoietic cells, such as MEFs and lung
fibroblast cells, following oxidative stress. Collectively, these
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TXNIP Is a Functional Switch in Oxidative Stressresults indicate that the amount of TXNIP is inversely associated
with the ROS level in hematopoietic cells, and the loss of TXNIP
can increase ROS levels in a cell-type-specific manner.
p53 can protect cells against genotoxic damage by inducing
antiapoptotic and antioxidant genes (Bensaad and Vousden,
2007; Han et al., 2008; Ja¨nicke et al., 2008). Increased levels of
alternative reading frame protein of the Cdkn2a locus (ARF)
and p53 have been shown to decrease ROS levels in spleno-
cytes and increase their resistance to acute oxidative stress
following PA challenge (Matheu et al., 2007). p53/ mice
show increased levels of oxidation markers in tissue and hyper-
sensitivity to lipopolysaccharide (LPS)-induced septic shock
(Komarova et al., 2005). TXNIP and p53 appear to be involved
in overlapping aspects of cellular functions, including tumor sup-
pression, cell-cycle arrest, ROS regulation, and hematopoietic
cell maintenance, strongly suggesting that they cooperate to
regulate ROS levels in hematopoietic cells.
Here, we show that TXNIP interacts directly with p53 via
cysteine residues and increases p53 stability by inhibiting the
formation of the p53-MDM2 complex, thereby inducing the tran-
scriptional activity of p53. TXNIP also directly interacts with Trx
and inhibits interactions between Trx and other factors, such
as ASK-1 and PAG (Kim et al., 2007). TXNIP links oxidative stress
to inflammasome activation by interacting with NLRP3, and in-
flammasome activators induce the dissociation of TXNIP from
Trx in a ROS-sensitive manner (Zhou et al., 2010). We also found
that TXNIP was dissociated from Trx by oxidative stress. How-
ever, the interaction between TXNIP and p53 was increased by
oxidative stress. We recently reported that the association of
TXNIP with HDAC1 and HDAC3 via the cysteine 247 residue re-
sulted in the suppression of NF-kB activity (Kwon et al., 2010). A
recent report suggested that TXNIP-infected human embryonic
lung diploid fibroblast 2BS cells showed an induction of p53
and p21 during cellular senescence (Zhuo et al., 2010). The
above reports provided a clue as to how p53 may be regulated
by TXNIP. The tumor suppressor p53 contains ten cysteine res-
idues in its DNA-binding domain, and the reduction of cysteine
residues leads to enhanced binding, whereas oxidation abol-
ishes binding (Hainaut and Milner, 1993; Hupp et al., 1993; Rain-
water et al., 1995). Several proteins have been reported to inhibit
p53-MDM2 interactions through direct binding to p53 or MDM2
(Hsieh et al., 1999; Jung et al., 2007; Leung et al., 2002). For
example, NM23-H1 and STRAP (serine-threonine kinase recep-
tor-associated protein) interact with the DNA-binding domain of
p53 via cysteine residues and activate p53 activity by interfering
with the p53-MDM2 complex. ARF, the alternative reading frame
product of the INK4a/ARF locus, binds MDM2 and prevents
MDM2-mediated p53 degradation (Jung et al., 2008).
p53 can also activate an antioxidant transcriptional program
that could be relevant when p53 is activated by mild stresses
(Vousden and Lane, 2007). We showed the differential expres-
sion of p53 target genes in WT and KO cells, suggesting that
the induction of the p53 response program could be regulated
by TXNIP. Reduction of the antioxidant genes in KO hematopoi-
etic cells might lead to an imbalance in the intracellular defense
system, and KO hematopoietic cells showed elevated ROS
levels and became more sensitive to oxidative stress. We de-
tected higher levels of p53 and its target genes in old KO BM
cells due to hyperphysiological ROS levels, which led toapoptosis and cell-cycle arrest. p53 exerts different effects on
cellular redox status by directly regulating the expression of
prooxidant or antioxidant genes, depending on the strength of
the oxidative stress (Liu et al., 2005; Sablina et al., 2005; Stam-
bolsky et al., 2006). However, the key regulatory molecule
responsible for switching p53 function from antioxidant to pro-
oxidant in response to different levels of oxidative stress has
not yet been discovered. In this study, we observed that p53
functions as an antioxidant in WT BM cells, but it could also
function as a prooxidant in KO BM cells with elevated ROS.
Therefore, we propose that TXNIP acts as a functional switch
to determine the cellular function of p53 in hematopoietic cells
in response to oxidative stress (Figure 7H).
In conclusion, we found that TXNIP plays important roles in the
maintenance of the hematopoietic cells by regulating the p53
pathway. KO mice showed reduced hematopoietic cell popula-
tion, impaired hematopoietic cell maintenance, and increased
apoptosis following oxidative stress, leading to death after PA
challenge. Restoring TXNIP and p53 expression rescued he-
matopoietic cell pool and mice survival under oxidative stress.
These results suggest that modulating TXNIP and p53 interac-
tions could potentially be a therapeutic target for oxidative




TXNIP KOmice were generated as described previously (Lee et al., 2005), and
congenic CD45.1+ C57BL/6 mice and p53/ mice (B6.129S2-Trp53tm1Tyj/J)
were purchased from Jackson Laboratory. All mice were housed in a path-
ogen-free animal facility under a 12 hr light-dark cycle, and we used young
(8–12 weeks) and old (22–23 months) male mice. p53/, Txnip/ (KO), and
WT mice were injected i.p. with 40, 50, or 80 mg/kg PA and 100 mg/kg NAC
(Sigma-Aldrich) or 5 mg/kg PFT-a (Sigma-Aldrich). All experiments were per-
formed in compliance with the Guide for the Care and Use of Laboratory
Animals, from the Institute for Laboratory Animal Research.
Preparation of BM Cells
Total BM cells were isolated from mouse femurs, tibias, hip bones, and shoul-
der bones by grinding tissues in RPMI 1640 medium (WelGENE) plus 2% fetal
bovine serum (FBS). Red blood cells (RBCs) were lysed using ACK buffer
(0.15 M NH4Cl, 1.0 mM KHCO3, 0.1 mM EDTA [pH 7.4]) or not, and the cells
were filtered through a strainer. Antibodies were purchased from BD Biosci-
ences or BioLegend. BM cells were stained as previously described (Jeong
et al., 2009) and analyzed using FACSCanto II, and LKS cells were sorted using
FACSAria Cell Sorter (BD Biosciences). For lineagec-Kit+ (LK) cell prepara-
tion, we used magnetic-activated cell sorting (MACS) purification methods.
Bone Marrow Transplantation
For competitive repopulation assays, WBM cells (2.03 106) or LKS cells (5.03
103) from young and old WT or KO mice (CD45.2+) and from congenic
(CD45.1+, 1.0 3 106) mice were mixed, and the mixture was intravenously
(i.v.) injected into lethally irradiated (9 Gy) WT congenic (CD45.1+) recipients.
The repopulation of donor-derived cells was monitored by staining peripheral
blood cells (PB) obtained from tail vein and BM cells with antibodies against
indicated surface markers. For noncompetitive transplantation, WBM cells
(2.5 3 106) from WT or KO mice were i.v. injected into lethally irradiated (9
Gy) WT congenic (CD45.1+) recipients and assayed after 8 weeks.
Detection of Intracellular ROS
Intracellular levels of ROS were measured by flow cytometry using the ROS-
specific fluorescent probes 5-(and 6)-chloromethyl-20,70-dichlorodihydrofluor-
escein diacetate, acetyl ester (DCF) (C6827) and dihydroethidium (DHE)Cell Metabolism 18, 75–85, July 2, 2013 ª2013 Elsevier Inc. 83
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TXNIP Is a Functional Switch in Oxidative Stress(D11347) (Invitrogen). Freshly isolated cells were incubated for 15 min at 37C
at a final concentration of 5 mMDCF or 2.5 mMDHE in PBS containing 2%FBS.
CFU-S and Radioprotection Assay
Lethally irradiated (9 Gy) WT congenic (CD45.1+) recipients were i.v. injected
with BM cells (1 3 105) from PBS or PA-treated WT and KO mice and spleens
were fixed in Carnoy’s solution (60% ethanol, 30% chloroform, 10% acetic
acid [v/v]), andmacroscopic colonies were counted after 7 days. For radiopro-
tection assay, we adjusted the number ofWTBMcells to keep a survival rate of
more than 60%after BMT. RBCswere lysed in donorWBMcells, and 1.53 105
BM cells from WT PBS, WT PA, KO PBS, or KO PA were injected into lethally
irradiated (9 Gy) congenic (CD45.1+) recipients. These results might explain
that themice that received enough number of HSCs from donor BM cells could
survive after BMT due to normal hematopoiesis. The recipient survival was
scored every day and presented as a Kaplan-Meier survival curve.
Cell Culture and Reporter Assay
A549, MCF7, HCT116 (+/+, /), and 293T cells were cultured in Dulbecco’s
modified Eagle’s medium (DMEM) or RPMI 1640 medium supplemented with
10% FBS (HyClone). Baf3 (murine bone marrow-derived pro-B cell) cells were
cultured in RPMI 1640 medium supplemented with 10% FBS and 10 ng/ml
mouse interleukin-3 (IL-3). Lung fibroblast cells were isolated from WT or KO
mice as described previously (Huaux et al., 2003) and cultured in DMEM sup-
plemented with 10% FBS (we used 1–2 passages). MEF cells were prepared
from day 13.5 embryos, and we used 1–3 passages. Each construct was tran-
siently transfected with Lipofectamine and Plus (Invitrogen) or Amaxa Cell Line
Nucleofector Kit V (Lonza) according to the manufacturer’s instructions. Lucif-
erase activity was monitored by using a p53-luciferase reporter (Jung et al.,
2008), and Renilla luciferase expression vector (Promega) was cotransfected
as a control to monitor the transfection efficiency. The firefly and Renilla lucif-
erase activities were determined using the Dual-Luciferase Reporter Assay
System (Promega) (Jeong et al., 2009).
Statistical Analyses
The data are expressed as the mean ± SD of n determinations unless noted
otherwise, and Student’s t test was used to compare two groups. p < 0.05
was considered statistically significant.
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